August 4, 2025 · Form 4 insider transaction
Megna Michael R bought 17,000 shares of Kiniksa Pharmaceuticals Ltd. at $15.52 per share, a transaction worth $263.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024.